New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A1996

Introduced
1/9/24  
Refer
1/9/24  

Caption

Establishes requirements to screen certain people who are pregnant and who have given birth for preeclampsia.

Impact

If enacted, A1996 would introduce significant changes to maternal healthcare practices in New Jersey. By mandating that health facilities adopt screening protocols for preeclampsia and hypertensive disorders, the bill directly impacts the standards of care provided to pregnant individuals and new mothers. This initiative is anticipated to lead to early detection and treatment of potentially life-threatening conditions, thereby improving maternal health outcomes and reducing hospital readmission rates. The educational component of the bill also aims to raise awareness amongst healthcare providers and patients about the risks and symptoms associated with these conditions.

Summary

Assembly Bill A1996 aims to establish mandatory screenings for preeclampsia and related hypertensive disorders among pregnant individuals and those who have recently given birth. The bill requires all hospitals, birthing centers, and federally qualified health centers in New Jersey to implement policies ensuring that individuals showing symptoms of hypertensive disorders are screened unless they formally decline. The screening tools used must adhere to best practices as set by recognized medical boards, enhancing the standard of care for postpartum patients.

Sentiment

The sentiment surrounding A1996 appears to be predominantly positive, with many stakeholders, including healthcare providers and maternal health advocates, supporting the initiative. Proponents argue that the requirement for screening represents a proactive approach to safeguarding the health of mothers and infants. However, there may be underlying concerns regarding the implementation logistics, such as the adequacy of resources to conduct additional screenings and the training required for healthcare practitioners.

Contention

While there is broad support for the idea of enhanced screening for preeclampsia, some discussions highlight potential challenges regarding its implementation. Questions have been raised about the capacity of healthcare facilities to manage increased workloads, particularly in underserved areas. Additionally, while the bill strives for comprehensive maternal care, there are fears that without sufficient funding and support, the initiative may not achieve its intended outcomes, highlighting a need for ongoing dialogue between legislators and medical professionals to address these issues effectively.

Companion Bills

NJ S3047

Same As Establishes requirements to evaluate certain people who are pregnant and who have given birth for preeclampsia.

NJ A4457

Carry Over Establishes requirements to screen certain people who are pregnant and who have given birth for preeclampsia.

Similar Bills

PA HR158

Designating the month of May 2025 as "Preeclampsia Awareness Month" in Pennsylvania.

MS HB1025

Preeclampsia; Health Department prepare materials about complications of pregnancy due to, which providers shall provide to pregnant women.

NJ S3047

Establishes requirements to evaluate certain people who are pregnant and who have given birth for preeclampsia.

NJ S2218

Establishes requirements to screen certain people who are pregnant and who have given birth for endometriosis.

NJ A1973

Establishes requirements to evaluate certain people who are pregnant and who have given birth for endometriosis.

FL H6523

Relief/Darline Angervil and J.R./South Broward Hospital District

TX HB227

Relating to the creation of a maternal health care improvement program to address maternal morbidity.

CA AB54

Access to Safe Abortion Care Act.